What the name refers to
A bile acid that disrupts cell membranes; a specific synthetic formulation is authorised in the United States for submental fat.
Evidence and regulatory context
The broad ingredient name is not enough to determine approval. Regulatory status belongs to the exact finished product, formulation, intended use and jurisdiction.
Reading product records
This category is formulation- and jurisdiction-dependent. A useful record names the complete product, manufacturer, authorised distributor, batch and intended indication. An ingredient assay alone cannot establish sterility, clinical suitability or a legitimate supply chain.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.